Items where authors include "Gautam, R."

Article

Kabra, M. orcid.org/0000-0001-5089-9892, Srivastava, T., Gautam, R. et al. (9 more authors) (2026) Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis. Journal of Comparative Effectiveness Research. e250171. ISSN 2042-6305

Shah, B., Challagulla, S., Xu, S. et al. (7 more authors) (2025) Zanubrutinib versus acalabrutinib indirect treatment comparison in relapsed or refractory mantle cell lymphoma. Leukemia & Lymphoma, 66 (12). pp. 2238-2248. ISSN 1042-8194

Gautam, R., Priyadarshini, E., Maan, P. et al. (2 more authors) (2025) Exploring the association between arsenic exposure and sperm quality: a systematic review and meta-analysis. Journal of Human Reproductive Sciences, 18 (4). pp. 197-207. ISSN 0974-1208

Srivastava, T., Gupta, A., Gautam, R. et al. (2 more authors) (2024) SA46 Are we dealing with heterogeneity in network meta-analysis appropriately? A review of NICE submissions. Value in Health, 27 (6, Supplement). S403-S404. ISSN 1098-3015

Proceedings Paper

Shah, B., Challagulla, S., Xu, S. et al. (5 more authors) (2024) Indirect comparison of efficacy of zanubrutinib versus acalabrutinib in the treatment of relapsed/refractory (R/R) mantle cell lymphoma (MCL). In: Clinical Lymphoma Myeloma and Leukemia. Society of Hematologic Oncology 2024 Annual Meeting, 04-07 Sep 2024, Houston, Texas, USA. Elsevier BV , S227-S227.

Shah, B., Challagulla, S., Xu, S. et al. (5 more authors) (2024) MCL-509 Indirect comparison of efficacy of zanubrutinib versus acalabrutinib in the treatment of relapsed/refractory (R/R) mantle cell lymphoma (MCL). In: Clinical Lymphoma Myeloma and Leukemia. Society of Hematologic Oncology 2024 Annual Meeting, 04-07 Sep 2024, Houston, Texas. Elsevier BV , S516-S517.